Factors Affecting Response and Survival in Patients With Myelodysplasia Treated With Immunosuppressive Therapy

Abstract

IST produced significant improvement in the pancytopenia of a substantial proportion of patients with MDS and was associated with improved overall and progression-free survival, especially in younger individuals with lower-risk disease.